Identification of human guanylate-binding protein 1 gene (hGBP1) as a direct transcriptional target gene of p53

Biochemical and Biophysical Research Communications

Volumn 436, Issue 2, 2013, Pages 204-211

  Zhu, Zixiang ^a   Wei, Jianchao ^a   Shi, Zixue ^a   Yang, Yifan ^a   Shao, Donghua ^a   Li, Beibei ^a   Wang, Xiaodu ^b   Ma, Zhiyong ^a  

^a INSTITUTE OF PLANT PROTECTION   (China)

^b ZHEJIANG A F UNIVERSITY   (China)

Author keywords

Guanylate binding proteins; Human guanylate binding protein 1 gene; Interferon inducible protein; P53

Indexed keywords

ALPHA INTERFERON; FLUOROURACIL; PROTEIN P53;

ARTICLE; DNA DAMAGE; DNA RESPONSIVE ELEMENT; GENE ACTIVATION; GENE CONTROL; GENE EXPRESSION; GENE IDENTIFICATION; GENE TARGETING; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HUMAN GUANYLATE BINDING PROTEIN 1 GENE; INFLUENZA VIRUS A; ONCOGENE; PRIORITY JOURNAL; PROMOTER REGION; VIRUS INFECTION;

ANTIMETABOLITES, ANTINEOPLASTIC; BINDING SITES; BLOTTING, WESTERN; CELL LINE, TUMOR; FLUOROURACIL; GENE EXPRESSION REGULATION, NEOPLASTIC; GTP-BINDING PROTEINS; HCT116 CELLS; HEP G2 CELLS; HUMANS; INTERFERON TYPE I; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; RESPONSE ELEMENTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; TRANSCRIPTION, GENETIC; TRANSCRIPTIONAL ACTIVATION; TUMOR SUPPRESSOR PROTEIN P53;

INFLUENZA A VIRUS;

EID: 84879600980     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2013.05.074     Document Type: Article

References (24)

1. Lipnik K., et al. Interferon gamma-induced human guanylate binding protein 1 inhibits mammary tumor growth in mice. Mol. Med. 2010, 16:177-187.
2. Vestal D.J., Jeyaratnam J.A. The guanylate-binding proteins: emerging insights into the biochemical properties and functions of this family of large interferon-induced guanosine triphosphatase. J. Interferon. Cytokine Res. 2011, 31:89-97.
3. Nordmann A., Wixler L., Boergeling Y., Wixler V., Ludwig S. A new splice variant of the human guanylate-binding protein 3 mediates anti-influenza activity through inhibition of viral transcription and replication. FASEB J. 2012, 26:1290-1300.
4. Kim B.H., Shenoy A.R., Kumar P., Das R., Tiwari S., MacMicking J.D. A family of IFN-gamma-inducible 65-kD GTPases protects against bacterial infection. Science 2011, 332:717-721.
5. Naschberger E., et al. Nuclear factor-kappaB motif and interferon-alpha-stimulated response element co-operate in the activation of guanylate-binding protein-1 expression by inflammatory cytokines in endothelial cells. Biochem. J. 2004, 379:409-420.
6. Rivas C., Aaronson S.A., Munoz-Fontela C. Dual role of p53 in innate antiviral immunity. Viruses 2010, 2:298-313.
7. Bouchet B.P., Caron D.F.C., Puisieux A., Galmarini C.M. P53 as a target for anti-cancer drug development. Crit. Rev. Oncol. Hematol. 2006, 58:190-207.
8. Clark D.W., Mitra A., Fillmore R.A., Jiang W.G., Samant R.S., Fodstad O., Shevde L.A. NUPR1 interacts with p53, transcriptionally regulates p21 and rescues breast epithelial cells from doxorubicin-induced genotoxic stress. Curr. Cancer Drug Targets 2008, 8:421-430.
9. Hsu T.H., Chu C.C., Jiang S.Y., Hung M.W., Ni W.C., Lin H.E., Chang T.C. Expression of the class II tumor suppressor gene RIG1 is directly regulated by p53 tumor suppressor in cancer cell lines. FEBS Lett. 2012, 586:1287-1293.
10. Laptenko O., Prives C. Transcriptional regulation by p53: one protein, many possibilities. Cell Death Differ. 2006, 13:951-961.
11. De Angelis P.M., Svendsrud D.H., Kravik K.L., Stokke T. Cellular response to 5-fluorouracil (5-FU) in 5-FU-resistant colon cancer cell lines during treatment and recovery. Mol. Cancer 2006, 5:20.
12. Wang B., Xiao Z., Ren E.C. Redefining the p53 response element. Proc. Natl. Acad. Sci. USA 2009, 106:14373-14378.
13. Riley T., Sontag E., Chen P., Levine A. Transcriptional control of human p53-regulated genes. Nat. Rev. Mol. Cell Biol. 2008, 9:402-412.
14. Ma B., Levine A.J. Probing potential binding modes of the p53 tetramer to DNA based on the symmetries encoded in p53 response elements. Nucleic Acids Res. 2007, 35:7733-7747.
15. Zhu Z., et al. Nonstructural protein 1 of influenza A virus interacts with human guanylate-binding protein 1 to antagonize antiviral activity. Plos One 2013, 8:e55920.
16. Li X., Qiu Y., Shen Y., Ding C., Liu P., Zhou J., Ma Z. Splicing together different regions of a gene by modified polymerase chain reaction-based site-directed mutagenesis. Anal. Biochem. 2008, 373:398-400.
17. Sun X.X., Wang Y.G., Xirodimas D.P., Dai M.S. Perturbation of 60 S ribosomal biogenesis results in ribosomal protein L5- and L11-dependent p53 activation. J. Biol. Chem. 2010, 285:25812-25821.
18. Munoz-Fontela C., et al. p53 Serves as a host antiviral factor that enhances innate and adaptive immune responses to influenza A virus. J. Immunol. 2011, 187:6428-6436.
19. Takaoka A., et al. Integration of interferon-alpha/beta signalling to p53 responses in tumour suppression and antiviral defence. Nature 2003, 424:516-523.
20. Inga A., Storici F., Darden T.A., Resnick M.A. Differential transactivation by the p53 transcription factor is highly dependent on p53 level and promoter target sequence. Mol. Cell Biol. 2002, 22:8612-8625.
21. Osada M., et al. Differential recognition of response elements determines target gene specificity for p53 and p63. Mol. Cell Biol. 2005, 25:6077-6089.
22. Jordan J.J., Menendez D., Inga A., Noureddine M., Bell D.A., Resnick M.A. Noncanonical DNA motifs as transactivation targets by wild type and mutant p53. PLoS Genet 2008, 4:e1000104.
23. Munoz-Fontela C., Macip S., Martinez-Sobrido L., Brown L., Ashour J., Garcia-Sastre A., Lee S.W., Aaronson S.A. Transcriptional role of p53 in interferon-mediated antiviral immunity. J. Exp. Med. 2008, 205:1929-1938.
24. Olszewski M.A., Gray J., Vestal D.J. In silico genomic analysis of the human and murine guanylate-binding protein (GBP) gene clusters. J. Interferon Cytokine Res. 2006, 26:328-352.